(S)-Timolol maleate Good Manufacturer supply High Quality 26921-17-5
- Molecular Formula:C13H24N4O3S.C4H4O4
- Molecular Weight:432.498
- Vapor Pressure:7.7E-21mmHg at 25°C
- Melting Point:202-203 °C(lit.)
- Boiling Point:487.2 °C at 760 mmHg
- Flash Point:248.5 °C
- PSA：182.58000
- LogP:0.67020
(S)-Timolol maleate (26921-17-5) Usage
Timolol is a non-selective β-adrenergic receptor antagonist with log Kd values of -8.27, -9.86, and -6.8 for binding to human β1-, β2-, and β3-adrenoceptors, respectively. It has been reported that only the (S) enantiomer contributes to the β-blocking effects of racemic timolol, but the weakly active (R) isomer maintains a beneficial effect on intraocular pressure without the undesirable side-effect of bronchial constriction caused by non-selective action of (S)-timolol on β1 and β2 receptors. Timolol has been use alone and in fixed combinations with either prostaglandin analogs or carbonic anhydrase inhibitors to reduce intraocular pressure in research models of ocular hypertension and glaucoma.
How to get the best price on (S)-Timolol maleate?
Zibo Hangyu Biotechnology Development Co., Ltd is a quality supplier and manufacturer of (S)-Timolol maleate . You can buy high quality, low price (S)-Timolol maleate 26921-17-5 here.
Zibo Hangyu Biotechnology Development Co., Ltd. is a comprehensive chemical enterprise focusing on fine chemical products and pharmaceutical intermediates, integrating research and development, production and sales. The company is equipped with advanced equipment quality inspection and research center. At the same time, the company has excellent talents with rich experience in process development and quality control. To provide customers with total solutions from raw material processing to chemical synthesis systems. The company has established a standardized and perfect quality standard system to provide stable and high quality production and service.
Milestones
- 2012yearThe company was founded, began to engage in the production and supply of chemical raw materials
- 2014yearExpand the scale of production, pharmaceutical raw materials production workshop was established
- 2016yearCooperated with domestic and foreign chemical platforms to promote self-produced and high-end pharmaceutical intermediates
- 2019yearIn recent years to participate in the international pharmaceutical raw materials exhibitions
- 2023yearBusiness continues to expand, Production and Sales teams continue to grow
- 2026yearPlans to set up foreign branches
